Article Information
History
- January 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Bongkot Ngamsoma,
- Alexander Ilesa,
- Moses Kamitab,
- Racheal Kimanib,
- Pablo Rodriguez-Mateosa,
- Mary Mungaic,
- Charlotte E. Dyerd,
- Cheryl Walterd,
- Jesse Gitakab,1,* and
- Nicole Pammea,e,1,*
- aDepartment of Chemistry and Biochemistry, University of Hull, Hull, HU6 7RX, UK
- bDirectorate of Research and Innovation, Mount Kenya University, Thika, Kenya
- cCentre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
- dDepartment of Biomedical Sciences, University of Hull, Hull, HU6 7RX, UK
- eDepartment of Materials and Environmental Chemistry, Stockholm University, SE-106 91, Sweden
- ↵1To whom correspondence should be addressed. Email: nicole.pamme{at}mmk.su.se; jgitaka{at}mku.ac.ke.
Posted January 06, 2022.
An integrated lab-on-a-chip device for RNA extraction, amplification and CRISPR-Cas12a-assisted detection for COVID-19 screening in resource-limited settings
